Division of Oral and Maxillofacial Surgery 2, Department of Diagnostic and Therapeutic Sciences, School of Dentistry, Meikai University, Saitama, Japan.
Int J Oncol. 2013 Sep;43(3):729-36. doi: 10.3892/ijo.2013.1990. Epub 2013 Jun 25.
Progression of oral carcinomas associates with aberrant activation and inactivation of molecules that work in established or unknown pathways. Although mucosa‑associated lymphoid tissue 1 (MALT1) expressed in normal oral epithelium is inactivated in the aggressive subset of carcinomas with worse prognosis, phenotypic changes of carcinoma cells upon the loss of expression is unknown. We performed a proteomic analysis to identify MALT1‑regulated proteins in oral carcinoma cells. Four different keratins were included in the ten most abundantly changed proteins. K8/18 were upregulated in MALT1 stably‑expressing carcinoma cells and K5/14 in MALT1‑marginal control cells. K8/18 upregulation and K5/14 downregulation were MALT1 dose‑dependent and observed in a series of oral carcinoma cells. MALT1 suppressed cell proliferation (0.52-fold, P<0.01) and its dominant-negative form stimulated it (1.33-fold, P<0.01). The decreased proliferation associated with reduction of cyclin D1, which was recovered by the short interfering RNA against MALT1. Taken together, loss of MALT1 expression alters keratin expression and enhances proliferation of carcinoma cells, and may progress oral carcinomas into the advanced state.
口腔癌的进展与在既定或未知途径中起作用的分子的异常激活和失活有关。尽管正常口腔上皮中表达的黏膜相关淋巴组织 1(MALT1)在预后较差的侵袭性癌亚群中失活,但表达缺失后癌细胞的表型变化尚不清楚。我们进行了蛋白质组学分析,以鉴定口腔癌细胞中受 MALT1 调节的蛋白质。四种不同的角蛋白被包含在十种变化最明显的蛋白质中。MALT1 稳定表达的癌细胞中 K8/18 上调,而 MALT1 边缘对照细胞中 K5/14 下调。K8/18 的上调和 K5/14 的下调是 MALT1 剂量依赖性的,并在一系列口腔癌细胞中观察到。MALT1 抑制细胞增殖(0.52 倍,P<0.01),其显性失活形式刺激其增殖(1.33 倍,P<0.01)。增殖减少与细胞周期蛋白 D1 的减少有关,而 MALT1 的短发夹 RNA 可恢复其表达。总之,MALT1 表达的丧失改变了角蛋白的表达并增强了癌细胞的增殖,并且可能使口腔癌进展为晚期状态。